RxSight (RXST) Research & Development (2020 - 2026)
RxSight's (RXST) quarterly Research & Development came in at $9.5 million in Q1 2026, down 8.63% YoY from $10.4 million in Q1 2025, and up 6.37% on a QoQ basis from $8.9 million in Q4 2025.
RxSight (RXST) Research & Development (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Research & Development data on file, last reported at $9.5 million in Q1 2026.
- Quarterly Research & Development fell 8.63% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.7 million (up 2.59% YoY) and the FY2025 annual result came in at $38.5 million, up 12.17% from the prior year.
- Research & Development rose to $9.5 million in Q1 2026, from $8.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $10.4 million in Q1 2025 to a low of $6.2 million in Q2 2022.
- A 5-year average of $8.1 million and a median of $8.0 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2025 — Research & Development grew 29.09% — and 2026, when it retreated 8.63%.
- Tracing RXST's Research & Development over 5 years: stood at $6.7 million in 2022, then grew by 9.88% to $7.3 million in 2023, then gained by 25.42% to $9.2 million in 2024, then dropped by 3.28% to $8.9 million in 2025, then advanced by 6.37% to $9.5 million in 2026.
- The last three Research & Development figures came in at $9.5 million (Q1 2026), $8.9 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | RxSight | 253.92 Mn | -150.32 Mn | - | 9.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.24 Mn |
| Mar 31, 2026 | 9.47 Mn |
| Dec 31, 2025 | 8.91 Mn |
| Sep 30, 2025 | 9.06 Mn |
| Jun 30, 2025 | 10.22 Mn |
| Mar 31, 2025 | 10.37 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 8.84 Mn |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | 8.03 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Sep 30, 2023 | 7.10 Mn |
| Jun 30, 2023 | 7.40 Mn |
| Mar 31, 2023 | 7.21 Mn |
| Dec 31, 2022 | 6.68 Mn |
| Sep 30, 2022 | 6.39 Mn |
| Jun 30, 2022 | 6.19 Mn |
| Mar 31, 2022 | 6.72 Mn |
| Dec 31, 2021 | 5.92 Mn |
| Sep 30, 2021 | 5.38 Mn |